Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
C10orf35 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SRXN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GLA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PIR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PHF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PSAP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
B4GALNT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PSMC5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PSMB3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RBM11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DGKG - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UFD1L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DYNC1I1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PSMD12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VCP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AIFM2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
YPEL4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRMT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on